IL-33 (human) (rec.) (His)

CHF 510.00
In stock
CHI-HR-20033-C02020 µgCHF 510.00
CHI-HR-20033-C05050 µgCHF 770.00
 
More Information
Product Details
Synonyms Interleukin-33; IL-1F11; NF-HEV
Product Type Protein
Properties
Source/Host E. coli
Sequence Human IL-33 (aa 112-270) is fused at the N-terminus to a His-tag.
Crossreactivity Human
Purity ≥98% (SDS-PAGE)
Endotoxin Content <1EU/μg protein (LAL test; Lonza).
Reconstitution Reconstituted in sterile H2O not less than 100μg/ml, which can then be further diluted in other aqueous solutions.
Formulation Lyophilized from 0.2μm-filtered solution in PBS (pH 7.4).
Other Product Data NCBI reference AAH47085.1: IL-33 (human)
Declaration Manufactured by Chimerigen.
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Working aliquots are stable for up to 3 months when stored at -20°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Interleukin-33 (IL-33; HF-NEV; IL-1F11), a member of the IL-1 family of cytokines, is expressed by many cell types following pro-inflammatory stimulation and is thought to be released upon cell lysis. IL33 binds to and signals through ST2 (IL1R1) and its stimulation recruits MYD88, IRAK, IRAK4, and TRAF6, followed by phosphorylation of ERK1(MAPK3)/ERK2(MAPK1), p38(MAPK14), and JNK. The ability of IL-33 to target numerous immune cell types, like Th2-like cells, mast cells, and B1 cells, and to induce cytokine and chemokine production underlines its potential in influencing the outcome of a wide range of diseases, such as arthritis, asthma, atopic allergy & anaphylaxis, cardiovascular disease/atherosclerosis, nervous system diseases, and sepsis.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.